Decreases the relative expression levels of SREBP-2 and HMG-CoA reductase, TC contents in blood and liver, increases the expression level of CYP7A1 to improve lipid levels in blood and lipid metabolism disorders. The gene discussed is SREBF2; the disease is Disorder of lipid metabolism.